Article
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
European heart journal - 31 Jul 2021
Verstraelen Tom E, van Lint Freyja H M, Bosman Laurens P, de Brouwer Remco, Proost Virginnio M, Abeln Bob G S, Taha Karim, Zwinderman Aeilko H, Dickhoff Cathelijne, Oomen Toon, Schoonderwoerd Bas A, Kimman Gerardus P, Houweling Arjan C, Gimeno-Blanes Juan R, Asselbergs Folkert W, van der Zwaag Paul A, de Boer Rudolf A, van den Berg Maarten P, van Tintelen J Peter, Wilde Arthur A M
Abstract excerpt
AIMS: This study aims to improve risk stratification for primary prevention implantable cardioverter defibrillator (ICD) implantation by developing a new mutation-specific prediction model for malignant ventricular arrhythmia (VA) in phospholamban (PLN) p.Arg14del mutation carriers. The proposed model is compared to an existing PLN risk model. METHODS AND RESULTS: Data were collected from PLN p.Arg14del mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
